RNU6-998P

Across TCGA pan-cancer cohorts, RNU6-998P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-998P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RNU6-998P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-998P expression acts as an unfavorable survival marker, although some lineages such as LIHC and LUAD show a favorable association.

TGCT, CHOL, and KICH are the cancer types where RNU6-998P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	54	view →
CHOL	DFS	Tertile	II,III,IV	0.094	0.446	.007	36	view →
KICH	DFS	Tertile	II,III,IV	0.348	0.916	.001	30	view →
THCA	DFS	Tertile	IV	0.572	0.874	.016	24	view →
GBM	DFS	Tertile	All	0.143	0.314	.026	18	view →
ACC	OS	Tertile	III,IV	0.189	0.757	<.001	18	view →
LIHC	OS	Tertile	II,III,IV	1.000	0.710	.015	15	view →
COAD	DFS	Tertile	IV	0.198	0.500	.033	9	view →
MESO	DFS	Tertile	III,IV	0.239	0.438	.037	9	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	9	view →
PCPG	OS	Tertile	All	0.925	1.000	.017	9	view →
LUAD	DFS	Tertile	III,IV	0.810	0.546	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-998P–TGCT (OS)

Open the TGCT breakdown →